NIAID Banner Logo Image

Mycobacterium Citations List: January, 2020

Literature Citations

1. Evaluation of Thio- and Seleno-acetamides Bearing Benzenesulfonamide as Inhibitor of Carbonic anhydrases from Different Pathogenic Bacteria. Angeli, A., M. Pinteala, S.S. Maier, B.C. Simionescu, A. Milaneschi, G. Abbas, S. Del Prete, C. Capasso, A. Capperucci, D. Tanini, F. Carta, and C.T. Supuran. International Journal of Molecular Sciences, 2020. 21(2): E598. PMID[31963423].
[PubMed]. TB_01_2020.

2. Usnic acid Enaminone-coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents. Bangalore, P.K., S.K. Vagolu, R.K. Bollikanda, D.K. Veeragoni, P.C. Choudante, S. Misra, D. Sriram, B. Sridhar, and S. Kantevari. Journal of Natural Products, 2020. 83(1): p. 26-35. PMID[31858800].
[PubMed]. TB_01_2020.

3. Bactericidal Effect of Pyridine-2-thiol 1-oxide Sodium Salt and Its Complex with Iron against Resistant Clinical Isolates of Mycobacterium tuberculosis. Campos, D.L., I. Machado, C.M. Ribeiro, D. Gambino, and F.R. Pavan. The Journal of Antibiotics, 2020. 73(2): p. 120-124. PMID[31619772].
[PubMed]. TB_01_2020.

4. Electrochemistry of Ring-substituted 1-Hydroxynaphthalene-2-carboxanilides: Relation to Structure and Biological Activity. Gajdár, J., K. Tsami, H. Michnová, T. Goněc, M. Brázdová, Z. Soldánová, M. Fojta, J. Jampílek, J. Barek, and J. Fischer. Electrochimica Acta, 2020. 332(135485). ISI[000506201800049].
[WOS]. TB_01_20.

5. Antimicrobial Activity of Quinoline-based Hydroxyimidazolium Hybrids. Insuasty, D., O. Vidal, A. Bernal, E. Marquez, J. Guzman, B. Insuasty, J. Quiroga, L. Svetaz, S. Zacchino, G. Puerto, and R. Abonia. Antibiotics, 2019. 8(4): p. 239. PMID[31795101]. PMCID[PMC6963836].
[PubMed]. TB_01_2020.

6. Large-scale Chemical-genetic Strategy Enables the Design of Antimicrobial Combination Chemotherapy in Mycobacteria. Johnson, E.O., E. Office, T. Kawate, M. Orzechowski, and D.T. Hung. ACS Infectious Diseases, 2020. 6(1): p. 56-63. PMID[31721551]. PMCID[PMC6958538].
[PubMed]. TB_01_2020.

7. Discovery of New and Potent InhA Inhibitors as Antituberculosis Agents: Structure-based Virtual Screening Validated by Biological Assays and X-ray Crystallography. Kamsri, P., C. Hanwarinroj, N. Phusi, T. Pornprom, K. Chayajarus, A. Punkvang, N. Suttipanta, P. Srimanote, K. Suttisintong, C. Songsiriritthigul, P. Saparpakorn, S. Hannongbua, S. Rattanabunyong, S. Seetaha, K. Choowongkomon, S. Sureram, P. Kittakoop, P. Hongmanee, P. Santanirand, Z. Chen, W. Zhu, R.A. Blood, Y. Takebayashi, P. Hinchliffe, A.J. Mulholland, J. Spencer, and P. Pungpo. Journal of Chemical Information and Modeling, 2020. 60(1): p. 226-234. PMID[31820972].
[PubMed]. TB_01_2020.

8. Synthesis and anti-Mycobacterium tuberculosis Activity of Imide-b-carboline and Carbomethoxy-b-carboline Derivatives. Lopes-Ortiz, M.A., M.R. Panice, E. Borges de Melo, J.P. Ataide Martins, V.P. Baldin, C.T. Agostinho Pires, K.R. Caleffi-Ferracioli, V.L. Dias Siqueira, R. Bertin de Lima Scodro, M.H. Sarragiotto, and R.F. Cardoso. European Journal of Medicinal Chemistry, 2020. 187: p. 111935. PMID[31816556].
[PubMed]. TB_01_2020.

9. Biological Properties of Volatile Oil from Brazilian Brown Propolis. Melo de Lima,V.H., K. de C. Rodrigues Almeida, C.C. Fernandes Alves, M.L. Rodrigues, A.E.M. Crottic, J.M. de Souz, A.B. Ribeiro, L.S. Squarisi, D.C. Tavares, C.H. Gomes Martins, and M.L. Dantas Miranda. Revista Brasileira De Farmacognosia, 2020. 29(6): p. 807-810. ISI[000503861400019].
[WOS]. TB_01_20.

10. Intracellular and in Vivo Evaluation of Imidazo[2,1-b]thiazole-5-carboxamide Anti-tuberculosis Compounds. Moraski, G.C., N. Deboosère, K.L. Marshall, H.A. Weaver, A. Vandeputte, C. Hastings, L. Woolhiser, A.J. Lenaerts, P. Brodin, and M.J. Miller. Plos One, 2020. 15(1): e0227224. PMID[31905374]. PMCID[PMC6944458].
[PubMed]. TB_01_2020.

11. Design, Synthesis and Biological Evaluation of 5-(2-(4-(Substituted benzo[d]isoxazol-3-yl) piperazin-1-yl)acetyl)indolin-2-one and 5-(2-(4-Substituted piperazin-1-yl)acetyl)indolin-2-one Analogues as Novel Anti-tubercular Agents. Naidu, K.M.G., Rudresh Naik; Sekhar, Kondapalli Venkata Gowri Chandra. Arabian Journal of Chemistry, 2019. 12(8): p. 2418-2429. ISI[000504900300067].
[WOS]. TB_01_20.

12. Synthesis, Biology, Computational Studies and in Vitro Controlled Release of New Isoniazid-based Adamantane Derivatives. Papageorgiou, A, A. S. Foscolos, I. P. Papanastasiou , M. Vlachou, A. Siamidi, A. Vocat, S.T. Cole, T.F. Kellici , T. Mavromoustakos, and A. Tsotinis. Future Medicinal Chemistry, 2019. 11(21). ISI[000503222000004].
[WOS]. TB_01_20.

13. Screening of Natural Compounds That Targets Glutamate racemase of Mycobacterium tuberculosis Reveals the Anti-tubercular Potential of Flavonoids. Pawar, A., P. Jha, M. Chopra, U. Chaudhry, and D. Saluja. Scientific Reports, 2020. 10(1): e949. PMID[31969615]. PMCID[PMC6976638].
[PubMed]. TB_01_2020.

14. Identification and Repurposing of Trisubstituted Harmine Derivatives as Novel Inhibitors of Mycobacterium tuberculosis Phosphoserine Phosphatase. Pierson, E., M. Haufroid, T.P. Gosain, P. Chopra, R. Singh, and J. Wouters. Molecules, 2020. 25(2): e415. PMID[31963843].
[PubMed]. TB_01_2020.

15. The Design and Green Synthesis of Novel Benzotriazoloquinolinyl spirooxindolopyrrolizidines: Antimycobacterial and Antiproliferative Studies. Pogaku, V., V.S. Krishna, C. Balachandran, K. Rangan, D. Sriram, S. Aoki, and S. Basavoju. New Journal of Chemistry, 2019. 43: p. 17511-17520. ISI[000503049000038].
[WOS]. TB_01_20.

16. The Bioisosteric Modification of Pyrazinamide Derivatives Led to Potent Antitubercular Agents: Synthesis via Click Approach and Molecular Docking of Pyrazine-1,2,3-triazoles. Reddyrajula, R. and U. Dalimba. Bioorganic & Medicinal Chemistry Letters, 2020. 30(2): e126846. PMID[31839540].
[PubMed]. TB_01_2020.

17. Two New Bioactive Triterpenoids from the Roots of Colubrina asiatica. Sangsopha, W., R. Lekphrom, F.T. Schevenels, K. Kanokmedhakul, and S. Kanokmedhakul. Natural Product Research, 2020. 34(4): p. 482-488. PMID[30445837].
[PubMed]. TB_01_2020.

18. Identification of Mycobacterium tuberculosis CtpF as a Target for Designing New Antituberculous Compounds. Santos, P., F. Lopez-Vallejo, D. Ramírez, J. Caballero, D. Mata Espinosa, R. Hernández-Pando, and C.Y. Soto. Bioorganic & Medicinal Chemistry, 2020. 28(3): e115256. PMID[31879181].
[PubMed]. TB_01_2020.

19. Development of (4-Methoxyphenyl)-1H-tetrazol-5-amine Regioisomers as a New Class of Selective Antitubercular Agents. Szulczyk, D., A. Bielenica, A. Głogowska, E. Augustynowicz-Kopeć, M. Dobrowolski, P. Roszkowski, K. Stępień, A. Chrzanowska, and M. Struga. European Journal of Medicinal Chemistry, 2020. 186: e111882. PMID[31753514].
[PubMed]. TB_01_2020.

20. Methyl Arachidonyl fluorophosphonate Inhibits Mycobacterium tuberculosis Thioesterase Tesa and Globally Affects Vancomycin Susceptibility. Yang, D., G. Vandenbussche, D. Vertommen, D. Evrard, R. Abskharon, J.-F. Cavalier, G. Berger, S. Canaan, M.S. Khan, S. Zeng, A. Wohlkönig, M. Prévost, P. Soumillion, and V. Fontaine. FEBS Letters, 2020. 594(1): p. 79-93. PMID[31388991].
[PubMed]. TB_01_2020.

Patent Citations

21. Compounds for Treating Infections Caused by Rifampicin-resistant Bacteria. Allenby, N., J. Errington, M. Hall, B. Kepplinger, H.M. Sejzi, and N. Zenkin. Patent. 2020. 2020-WO2020021252A1: 188pp.
[Patent]. TB_01_2020.

22. H37Rv Proliferation Inhibitor Based on (µ-Ethane-1,2-diol-O,O')-bis{[N-(2,3-dimethylphenyl)-2-(oxy-3-methoxybenzylidene)hydrazinecarbothioamido(1-)]aquacopper(Ii)} nitrate.Crudu, V., A. Gulea, and V. Ţapcov. Patent. 2020. 2020-MD4671B1.
[Patent]. TB_01_2020.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2020